TY  - RPRT
TI  - Cost-effectiveness analysis of HPV vaccination of boys in Belgium
AU  - Thiry Nancy
AU  - Gerkens Sophie
AU  - Cornelis Justien
AU  - Jespers Vicky
AU  - Hanquet Germaine
AB  - KCE Reports 308C (2019)

The vaccine for the human papilloma virus (HPV) which causes cervical cancer was introduced about ten years ago in Belgium, but only girls benefit from it. However, it is now established that this same virus is also involved in other cancers, including throat cancer.
T2  - KCE Reports
CY  - Brussels
PY  - 2019
LA  - English
M3  - Health Technology Assessment (HTA)
PB  - Belgian Health Care Knowledge Centre (KCE)
SN  - 308
VO  - D/2019/10.273/13
DO  - https://doi.org/10.57598/R308C
ER -